LIR Life Sciences Corp. (BBCMF)
OTCMKTS · Delayed Price · Currency is USD
1.000
+0.250 (33.33%)
At close: Feb 11, 2026
LIR Life Sciences Market Cap
LIR Life Sciences has a market cap or net worth of $26.57 million as of February 12, 2026.
Market Cap
26.57M
Enterprise Value
25.79M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.00
Market Cap Chart
Since November 7, 2025, LIR Life Sciences's market cap has increased from 16.43M to 26.57M, an increase of 61.73%. That is a compound annual growth rate of 510.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 26.57M | -28.55% |
| Dec 31, 2025 | 37.19M | 126.36% |
| Nov 7, 2025 | 16.43M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arch Biopartners | 43.72M |
| ZIVO Bioscience | 40.17M |
| Cell Source | 38.23M |
| Harvard Apparatus Regenerative Technology | 31.12M |
| Oncotelic Therapeutics | 27.82M |
| EOM Pharmaceuticals Holdings | 22.63M |
| Finch Therapeutics Group | 22.08M |
| Zenith Capital | 20.77M |